Viatris Inc. (VTRS) Ownership

NASDAQ: VTRSTop holders, insider trades and short interest.

VTRS ownership summary

as of October 18, 2026
Institutions
94.1%
of shares outstanding
Insiders
0.32%
of shares outstanding
Shares outstanding
1.15B
Float
1.14B
shares available to trade
Short interest
3.67%
42.0M shares short
Days to cover
4.65
short interest up 3.1% vs prior month
  • Institutions 94.13%
  • Insiders 0.32%
  • Other investors 5.55%

VTRS top institutional holders

20 largest
Viatris Inc. top institutional holders
#Holder% of sharesSharesValueChangeReported
1FMR Inc8.42%96.7M$1.80B+80.1M (+482.7%)June 30, 2026
2BlackRock Inc7.49%86.0M$1.61B+1.7M (+2.0%)June 30, 2026
3Vanguard Capital Management, LLC6.62%76.0M$1.42B+1.3M (+1.8%)June 30, 2026
4Davis Selected Advisers6.55%75.2M$1.40B−3.0M (−3.8%)June 30, 2026
5T. Rowe Price Associates, Inc.5.94%68.2M$1.27B+2.4M (+3.6%)June 30, 2026
6Vanguard Portfolio Management, LLC4.73%54.3M$1.01B+370,843 (+0.7%)June 30, 2026
7State Street Corp4.62%53.1M$990.3M+835,762 (+1.6%)June 30, 2026
8Rubric Capital Management LP2.97%34.2M$637.6M+668,743 (+2.0%)June 30, 2026
9Geode Capital Management, LLC2.86%32.8M$612.2M+961,799 (+3.0%)June 30, 2026
10Dimensional Fund Advisors, Inc.2.61%30.0M$559.2M−8.3M (−21.8%)June 30, 2026
11Amvescap Plc.1.81%20.8M$387.6M−1.2M (−5.5%)June 30, 2026
12Deerfield Management Co1.76%20.2M$377.0M—June 30, 2026
13Ameriprise Financial Inc1.64%18.8M$351.1M−1.2M (−6.0%)June 30, 2026
14Morgan Stanley - Brokerage Accounts1.32%15.1M$282.3M−961,040 (−6.0%)June 30, 2026
15Bank of New York Mellon Corp1.24%14.3M$266.6M+159,136 (+1.1%)June 30, 2026
16Charles Schwab Investment Management Inc1.18%13.6M$253.2M−106,964 (−0.8%)June 30, 2026
17The Goldman Sachs Group Inc1.18%13.6M$253.1M−152,750 (−1.1%)June 30, 2026
18Northern Trust Corp0.87%10.0M$187.3M−412,673 (−3.9%)June 30, 2026
19Assenagon Asset Management SA0.87%10.0M$186.2M+9.2M (+1,174.1%)June 30, 2026
20Glenview Capital Management LLC0.86%9.9M$184.3M+790,165 (+8.7%)June 30, 2026

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 11 holders added 98.4M shares and 8 cut 15.3M.

VTRS top mutual fund and ETF holders

20 largest
Viatris Inc. top fund holders
#Holder% of sharesSharesValueChangeReported
1Vanguard MStar Total Stk Mkt Idx Invest3.23%37.1M$691.6M−42,130 (−0.1%)August 31, 2026
2Vanguard 500 Index Investor2.69%30.9M$577.4M+366,730 (+1.2%)August 31, 2026
3Vanguard Small Cap Index2.33%26.8M$499.9M+23,200 (+0.1%)August 31, 2026
4Strategic Advisers Fidelity US TtlStk1.93%22.2M$414.1M+683,192 (+3.2%)August 31, 2026
5Davis NY Venture A1.77%20.3M$379.6M—August 31, 2026
6Vanguard MStar Small Cap Value Index1.48%17.0M$317.5M+12,902 (+0.1%)August 31, 2026
7iShares Core S&P 500 ETF1.33%15.3M$285.6M−24,642 (−0.2%)September 30, 2026
8Fidelity 500 Index1.32%15.1M$282.1M+58,022 (+0.4%)August 31, 2026
9State Street® SPDR® S&P 500® ETF1.23%14.1M$263.0M—September 30, 2026
10Invesco S&P 500® Equal Weight ETF1.03%11.9M$221.4M−24,605 (−0.2%)September 30, 2026
11T. Rowe Price Equity Income0.93%10.6M$198.6M—August 31, 2026
12State Street®HlthCrSelSectSPDR®ETF0.71%8.1M$152.0M+25,344 (+0.3%)September 30, 2026
13Fidelity Low-Priced Stock0.62%7.1M$133.2M+1.0M (+16.8%)July 31, 2026
14Fidelity Select Health Care0.61%7.0M$130.6M+1.0M (+16.7%)August 31, 2026
15T. Rowe Price Mid-Cap Value0.59%6.7M$125.6M−4,129 (−0.1%)August 31, 2026
16Selected American Shares S0.56%6.4M$120.2M—August 31, 2026
17Vanguard Institutional Index I0.54%6.2M$116.1M−64,779 (−1.0%)August 31, 2026
18Fidelity Select Pharmaceuticals Port0.47%5.4M$100.8M+368,800 (+7.3%)August 31, 2026
19Pacer US Cash Cows 100 ETF0.43%4.9M$91.6M−881 (−0.0%)September 30, 2026
20Fidelity Blue Chip Growth0.42%4.9M$91.0M+253,400 (+5.5%)August 31, 2026

Funds report holdings monthly or quarterly; dates differ by fund.

VTRS insider transactions

latest 7
Viatris Inc. insider transactions
DateNameTransactionPriceSharesValue
2026-03-23Paul CampbellSell$13.2821,350$283,528
2025-11-18Gilbert Ray Cisneros, Jr.Buy$10.71——
2025-11-03David S SimmonsBuy$10.43213$2,222
2025-09-11Goff Corinne LeSell$10.257,032$72,078
2025-08-27David S SimmonsBuy$10.42286$2,980
2025-08-12Scott Andrew SmithBuy$9.9922,000$219,780
2025-05-12Scott Andrew SmithBuy$8.9460,000$536,400

Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.

VTRS shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns VTRS

Institutional investors own 94.1% of Viatris's shares and insiders 0.32%. The largest holder is FMR Inc with 8.42% of the shares (96.7M), as of June 30, 2026. Among the top 20 institutions, 11 added shares and 8 reduced their stake in the latest filings. Short interest is 3.67% of the float, or 4.65 days of average trading volume. The share count rose 187.7% since 2014.

Related: VTRS analyst forecast, VTRS key metrics, VTRS dividend history. See the VTRS stock overview for the latest quote and news.

VTRS ownership FAQ

Who owns the most Viatris stock?

The largest shareholders of Viatris are FMR Inc (8.42%), BlackRock Inc (7.49%), Vanguard Capital Management, LLC (6.62%), Davis Selected Advisers (6.55%), T. Rowe Price Associates, Inc. (5.94%).

What percentage of Viatris is owned by institutions?

Institutions hold 94.1% of Viatris's shares outstanding; insiders hold 0.32%.

Which funds own Viatris?

The largest fund holders of Viatris are Vanguard MStar Total Stk Mkt Idx Invest (3.23%), Vanguard 500 Index Investor (2.69%), Vanguard Small Cap Index (2.33%), Strategic Advisers Fidelity US TtlStk (1.93%), Davis NY Venture A (1.77%).

What is Viatris's short interest?

42.0M shares of Viatris were sold short, 3.67% of the float; at the average daily volume it would take 4.65 days to cover.

Are insiders buying or selling Viatris?

Of the latest 7 reported insider transactions in Viatris (since May 12, 2025), 5 were purchases and 2 were sales.

How many shares of Viatris are outstanding?

Viatris has 1.15B shares outstanding, of which 1.14B are in the public float.

Drug Manufacturers - Specialty & Generic: ownership